• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, May 22

Pharma major Alembic Ltd has reported a 10 per cent slide in its net profit for the last fiscal to touch Rs 70.68 crore, against Rs 78.52 crore in the previous fiscal. The company said its net was hit as it had incurred a non-recurring expense of Rs 17.59 crore, including VRS of Rs. 7.82 crore, during the year. Its revenue was, however, higher by 8 per cent during the fiscal at Rs 721.83 crore, as compared with Rs 665.92 crore in the previous fiscal. In January this year, the company had announced the acquisition of non-oncology domestic formulation business of Dabur Pharma — the financial results of the acquisition will get reflected in its results from the current fiscal.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
JRG group consolidated net rises 69%

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line